臭氧联合阿德福韦酯胶囊治疗乙肝疗效观察

目的：研究臭氧联合阿德福韦酯胶囊对乙肝的治疗效果。方法：将同期就诊的112例患者按志愿接受治疗为原则，分为治疗组与对照组。治疗组：38例患者，予臭氧自血疗法联合阿德福韦酯胶囊，臭氧自血疗法疗程3个月，阿德福韦酯胶囊疗程18个月；对照A组：34例患者，单独使用口服阿德福韦酯胶囊，疗程18个月；对照B组：40例患者.单独使用臭氧自血疗法，疗程3个月。比较三组治疗后各项指标的变化。结果：治疗组联合应答率为47.3％；对照A组为38.2％：对照B组为40.0％。结论：臭氧自血疗法联合阿德福韦酯胶囊治疗乙肝疗效与单用阿德福韦酯胶囊近期疗效比较，差异具有统计学意义（P〈0.05）。该治疗方法起效快，值得临床应用。

A clinical observation of combining Ozone and Adefovir to treatment for hepatitis B

Objective: To study clinical effective of the ozone and adefovir treatment for HBV. Methods: Treatment of the same period 112 cases of patients receiving treatment in accordance with the principle of voluntary, for the treatment of 38 cases of group therapy to ozone joint adefovir capsules, ozone autohemotherapy treatment for 3 months, adefovir capsules treatment for 18 months; 34 cases as control group A, the use of oral adefovir capsules alone, treatment for 18 months; 40 cases for the control group B, given the ozone autohemotherapy for 3 months;over the same period three groups were detect-ed the various targets. Results: The treatment group for a joint response rate was 47.3%; and control group A was 38.2%; control group B was 40.0%. Conclusion: Compared the ozone joint adefovir therapy capsule in the treatment of hepatitis B with adefovir alone capsules have a significant difference in short-term efficacy (P<0.05). Improving the confidence in the treatment of patients.